Federal projects are rolling out A.I. agents that offer therapy and prescribe medicine, raising concerns about safety and the influence of venture capital investors.
Go to Source
Author: Christina Jewett
https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml

